Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Sensor augmented pump therapy from onset of type 1 diabetes: late follow-up results of the Pediatric Onset Study.

Kordonouri O, Hartmann R, Pankowska E, Rami B, Kapellen T, Coutant R, Lange K, Danne T.

Pediatr Diabetes. 2012 Nov;13(7):515-8. doi: 10.1111/j.1399-5448.2012.00863.x. Epub 2012 Apr 5.

PMID:
22487079
2.

Sensor-augmented pump therapy lowers HbA(1c) in suboptimally controlled Type 1 diabetes; a randomized controlled trial.

Hermanides J, Nørgaard K, Bruttomesso D, Mathieu C, Frid A, Dayan CM, Diem P, Fermon C, Wentholt IM, Hoekstra JB, DeVries JH.

Diabet Med. 2011 Oct;28(10):1158-67. doi: 10.1111/j.1464-5491.2011.03256.x.

PMID:
21294770
3.

Insulin pump therapy started at the time of diagnosis: effects on glycemic control and pancreatic β-cell function in type 1 diabetes.

Thrailkill KM, Moreau CS, Swearingen C, Rettiganti M, Edwards K, Morales AE, Kemp SF, Frindik JP, Fowlkes JL.

Diabetes Technol Ther. 2011 Oct;13(10):1023-30. doi: 10.1089/dia.2011.0085. Epub 2011 Jun 30.

PMID:
21718094
4.

Diabetes technology and treatments in the paediatric age group.

Shalitin S, Peter Chase H.

Int J Clin Pract Suppl. 2011 Feb;(170):76-82. doi: 10.1111/j.1742-1241.2010.02582.x. Review.

PMID:
21323816
5.

Sensor-augmented pump therapy from the diagnosis of childhood type 1 diabetes: results of the Paediatric Onset Study (ONSET) after 12 months of treatment.

Kordonouri O, Pankowska E, Rami B, Kapellen T, Coutant R, Hartmann R, Lange K, Knip M, Danne T.

Diabetologia. 2010 Dec;53(12):2487-95. doi: 10.1007/s00125-010-1878-6. Epub 2010 Aug 14.

PMID:
20711715
6.

Comparison between sensor-augmented insulin therapy with continuous subcutaneous insulin infusion or multiple daily injections in everyday life: 3-day analysis of glucose patterns and sensor accuracy in children.

Zucchini S, Scipione M, Balsamo C, Maltoni G, Rollo A, Molinari E, Mangoni L, Cicognani A.

Diabetes Technol Ther. 2011 Dec;13(12):1187-93. doi: 10.1089/dia.2011.0080. Epub 2011 Aug 19.

PMID:
21854193
7.
9.

A randomized prospective study of insulin pump vs. insulin injection therapy in very young children with type 1 diabetes: 12-month glycemic, BMI, and neurocognitive outcomes.

Nabhan ZM, Kreher NC, Greene DM, Eugster EA, Kronenberger W, DiMeglio LA.

Pediatr Diabetes. 2009 May;10(3):202-8. doi: 10.1111/j.1399-5448.2008.00494.x. Epub 2008 Dec 18.

PMID:
19140899
10.

Is there a difference in pregnancy and glycemic outcome in patients with type 1 diabetes on insulin pump with constant or intermittent glucose monitoring? A pilot study.

Petrovski G, Dimitrovski C, Bogoev M, Milenkovic T, Ahmeti I, Bitovska I.

Diabetes Technol Ther. 2011 Nov;13(11):1109-13. doi: 10.1089/dia.2011.0081. Epub 2011 Jul 13.

PMID:
21751889
11.

Insulin pumps in pediatric routine care improve long-term metabolic control without increasing the risk of hypoglycemia.

Hanas R, Adolfsson P.

Pediatr Diabetes. 2006 Feb;7(1):25-31. Erratum in: Pediatr Diabetes. 2006 Oct;7(5):298.

PMID:
16489971
12.

Assessment of use of specific features of subcutaneous insulin infusion systems and their relationship to metabolic control in patients with type 1 diabetes.

Quirós C, Patrascioiu I, Giménez M, Vinagre I, Vidal M, Jansà M, Conget I.

Endocrinol Nutr. 2014 Jun-Jul;61(6):318-22. doi: 10.1016/j.endonu.2014.01.003. Epub 2014 Feb 16. English, Spanish.

PMID:
24533929
13.

Effectiveness of sensor-augmented pump therapy in children and adolescents with type 1 diabetes in the STAR 3 study.

Slover RH, Welsh JB, Criego A, Weinzimer SA, Willi SM, Wood MA, Tamborlane WV.

Pediatr Diabetes. 2012 Feb;13(1):6-11. doi: 10.1111/j.1399-5448.2011.00793.x. Epub 2011 Jul 3.

PMID:
21722284
14.

Beta-cell response to intravenous glucagon in African-American and Hispanic children with type 2 diabetes mellitus.

Taha DR, Castells S, Umpaichitra V, Bastian W, Banerji MA.

J Pediatr Endocrinol Metab. 2002 Jan;15(1):59-67.

PMID:
11822582
15.

Treatment satisfaction in the sensor-augmented pump therapy for A1C reduction 3 (STAR 3) trial.

Peyrot M, Rubin RR; STAR 3 Study Group.

Diabet Med. 2013 Apr;30(4):464-7. doi: 10.1111/dme.12079.

PMID:
23496302
16.

Are the implications of the Diabetes Control and Complications Trial (DCCT) feasible in daily clinical practice?

Gautier JF, Beressi JP, Leblanc H, Vexiau P, Passa P.

Diabetes Metab. 1996 Dec;22(6):415-9.

PMID:
8985649
19.

Continuous subcutaneous insulin infusion pump treatment in children with type 1 diabetes mellitus.

Liberatore R Jr, Perlman K, Buccino J, Artiles-Sisk A, Daneman D.

J Pediatr Endocrinol Metab. 2004 Feb;17(2):223-6.

PMID:
15055358
20.

Application of novel dual wave meal bolus and its impact on glycated hemoglobin A1c level in children with type 1 diabetes.

Pańkowska E, Szypowska A, Lipka M, Szpotańska M, Błazik M, Groele L.

Pediatr Diabetes. 2009 Aug;10(5):298-303. doi: 10.1111/j.1399-5448.2008.00471.x. Epub 2008 Oct 20.

PMID:
19175902

Supplemental Content

Support Center